Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 147

Similar articles for PubMed (Select 22575864)

1.

Thyroid carcinoma-associated genetic mutations also occur in thyroid lymphomas.

Aggarwal N, Swerdlow SH, Kelly LM, Ogilvie JB, Nikiforova MN, Sathanoori M, Nikiforov YE.

Mod Pathol. 2012 Sep;25(9):1203-11. doi: 10.1038/modpathol.2012.73. Epub 2012 May 11.

2.

Concomitant RAS, RET/PTC, or BRAF mutations in advanced stage of papillary thyroid carcinoma.

Zou M, Baitei EY, Alzahrani AS, BinHumaid FS, Alkhafaji D, Al-Rijjal RA, Meyer BF, Shi Y.

Thyroid. 2014 Aug;24(8):1256-66. doi: 10.1089/thy.2013.0610. Epub 2014 Jun 10.

3.

Deviated VH4 immunoglobulin gene usage is found among thyroid mucosa-associated lymphoid tissue lymphomas, similar to the usage at other sites, but is not found in thyroid diffuse large B-cell lymphomas.

Sato Y, Nakamura N, Nakamura S, Sakugawa S, Ichimura K, Tanaka T, Ohara N, Oka T, Kondo E, Yoshino T.

Mod Pathol. 2006 Dec;19(12):1578-84. Epub 2006 Sep 15.

4.

Oncogenic mutations and chromosomal aberrations in primary extranodal diffuse large B-cell lymphomas of the thyroid--a study of 21 cases.

Knief J, Gebauer N, Bernard V, Schemme J, Reddemann K, Gebauer J, Rades D, Brabant G, Lehnert H, Feller AC, Thorns C.

J Clin Endocrinol Metab. 2015 Feb;100(2):754-62. doi: 10.1210/jc.2014-3250. Epub 2014 Nov 25.

PMID:
25423572
5.

PAX8-PPARgamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma.

Castro P, Rebocho AP, Soares RJ, Magalhães J, Roque L, Trovisco V, Vieira de Castro I, Cardoso-de-Oliveira M, Fonseca E, Soares P, Sobrinho-Simões M.

J Clin Endocrinol Metab. 2006 Jan;91(1):213-20. Epub 2005 Oct 11.

PMID:
16219715
6.

T(14;18)(q32;q21) involving MALT1 and IGH genes occurs in extranodal diffuse large B-cell lymphomas of the breast and testis.

Kuper-Hommel MJ, Schreuder MI, Gemmink AH, van Krieken JH.

Mod Pathol. 2013 Mar;26(3):421-7. doi: 10.1038/modpathol.2012.170. Epub 2012 Sep 28.

7.
8.
9.

Presence of simian virus 40 in diffuse large B-cell lymphomas in Tunisia correlates with germinal center B-cell immunophenotype, t(14;18) translocation, and P53 accumulation.

Amara K, Trimeche M, Ziadi S, Laatiri A, Mestiri S, Sriha B, Mokni M, Korbi S.

Mod Pathol. 2008 Mar;21(3):282-96. doi: 10.1038/modpathol.3800993. Epub 2007 Dec 28.

10.

Enhanced B-Raf protein expression is independent of V600E mutant status in thyroid carcinomas.

Kondo T, Nakazawa T, Murata S, Kurebayashi J, Ezzat S, Asa SL, Katoh R.

Hum Pathol. 2007 Dec;38(12):1810-8. Epub 2007 Aug 21.

PMID:
17714762
11.

B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome.

Li S, Lin P, Fayad LE, Lennon PA, Miranda RN, Yin CC, Lin E, Medeiros LJ.

Mod Pathol. 2012 Jan;25(1):145-56. doi: 10.1038/modpathol.2011.147. Epub 2011 Oct 14.

12.

BRAF and RAS mutations in follicular variants of papillary thyroid carcinoma.

Park JY, Kim WY, Hwang TS, Lee SS, Kim H, Han HS, Lim SD, Kim WS, Yoo YB, Park KS.

Endocr Pathol. 2013 Jun;24(2):69-76. doi: 10.1007/s12022-013-9244-0.

PMID:
23625203
13.

Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histological subtypes (encapsulated vs infiltrative) reveals distinct BRAF and RAS mutation patterns.

Rivera M, Ricarte-Filho J, Knauf J, Shaha A, Tuttle M, Fagin JA, Ghossein RA.

Mod Pathol. 2010 Sep;23(9):1191-200. doi: 10.1038/modpathol.2010.112. Epub 2010 Jun 4.

14.

Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations.

Quiros RM, Ding HG, Gattuso P, Prinz RA, Xu X.

Cancer. 2005 Jun 1;103(11):2261-8. Review.

15.

Mutational screening of RET, HRAS, KRAS, NRAS, BRAF, AKT1, and CTNNB1 in medullary thyroid carcinoma.

Schulten HJ, Al-Maghrabi J, Al-Ghamdi K, Salama S, Al-Muhayawi S, Chaudhary A, Hamour O, Abuzenadah A, Gari M, Al-Qahtani M.

Anticancer Res. 2011 Dec;31(12):4179-83.

PMID:
22199277
16.

Absence of BRAF, NRAS, KRAS, HRAS mutations, and RET/PTC gene rearrangements distinguishes dominant nodules in Hashimoto thyroiditis from papillary thyroid carcinomas.

Sadow PM, Heinrich MC, Corless CL, Fletcher JA, Nosé V.

Endocr Pathol. 2010 Jun;21(2):73-9. doi: 10.1007/s12022-009-9101-3.

PMID:
20012784
17.

Targeting BRAFV600E in thyroid carcinoma: therapeutic implications.

Mitsiades CS, Negri J, McMullan C, McMillin DW, Sozopoulos E, Fanourakis G, Voutsinas G, Tseleni-Balafouta S, Poulaki V, Batt D, Mitsiades N.

Mol Cancer Ther. 2007 Mar;6(3):1070-8.

18.

AIDS and non-AIDS diffuse large B-cell lymphomas express different antigen profiles.

Madan R, Gormley R, Dulau A, Xu D, Walsh D, Ramesh KH, Cannizaro L, Tamas EF, Kumar P, Sparano J, LeValley A, Xue X, Bhattacharyya PK, Ioachim HL, Ratech H.

Mod Pathol. 2006 Mar;19(3):438-46.

19.

Cutaneous b-cell lymphomas of follicular and marginal zone types: use of Bcl-6, CD10, Bcl-2, and CD21 in differential diagnosis and classification.

de Leval L, Harris NL, Longtine J, Ferry JA, Duncan LM.

Am J Surg Pathol. 2001 Jun;25(6):732-41.

PMID:
11395550
20.

Expression of HGAL in primary cutaneous large B-cell lymphomas: evidence for germinal center derivation of primary cutaneous follicular lymphoma.

Xie X, Sundram U, Natkunam Y, Kohler S, Hoppe RT, Kim YH, Cook JR, Hammel J, Swerdlow SH, Guitart J, Smith MD, Bosler D, Listinsky C, Lossos IS, Hsi ED.

Mod Pathol. 2008 Jun;21(6):653-9. doi: 10.1038/modpathol.2008.30. Epub 2008 Feb 8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk